VELSIPITY Film-coated tablet Ref.[108803] Active ingredients: Etrasimod

Source: European Medicines Agency (EU)  Revision Year: 2024  Publisher: Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Brussels, Belgium

Product name and form

Velsipity 2 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet (tablet).

Green, round, film-coated tablet of approximately 6 mm diameter, debossed with “ETR” on one side and “2” on the other side.

Qualitative and quantitative composition

Each film-coated tablet contains etrasimod arginine equivalent to 2 mg etrasimod.

Excipient with known effect: Each film-coated tablet contains 0.0156 mg of the colouring agent tartrazine (E102).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Etrasimod

Etrasimod is a sphingosine-1-phosphate (S1P) receptor modulator that binds to S1P receptors 1, 4 and 5 (S1P1,4,5) and is a balanced G-protein and beta-arrestin agonist at S1P1. Etrasimod has minimal activity on S1P3 and no activity on S1P2. Etrasimod partially and reversibly blocks the capacity of lymphocytes to egress from lymphoid organs, reducing the number of lymphocytes in peripheral blood thereby lowering the number of activated lymphocytes in the tissue. The mechanism by which etrasimod exerts therapeutic effects in ulcerative colitis is unknown but may involve the reduction of lymphocyte migration into sites of inflammation.

List of Excipients

Tablet core:

Magnesium stearate (E470b)
Mannitol (E421)
Microcrystalline cellulose (E460i)
Sodium starch glycolate (Type A)

Tablet coating:

Brilliant blue FCF aluminium lake (E133)
Indigo carmine aluminium lake (E132)
Tartrazine aluminium lake (E102)
Macrogol 4000 (E1521)
Poly(vinyl alcohol) (E1203)
Talc (E553b)
Titanium dioxide (E171)

Pack sizes and marketing

High-density polyethylene (HDPE) bottle closed with a polypropylene cap, desiccant integrated directly into the cap. Pack size of 30 film-coated tablets.

Aluminium blister strip laminated to an oriented polyamine (oPA) film and integrated desiccant layer (HDPE/LDPE), with a paper/aluminium/LDPE backing. Pack size of 28 or 98 film-coated tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Brussels, Belgium

Marketing authorization dates and numbers

EU/1/23/1790/001
EU/1/23/1790/002
EU/1/23/1790/003

Drugs

Drug Countries
VELSIPITY Austria, Canada, Estonia, France, Croatia, Ireland, Italy, Lithuania, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.